Innovative uses for zinc in dermatology

Dermatologic Clinics

Volumn 28, Issue 3, 2010, Pages 587-597

  Bae, Yoon Soo ^a   Hill, Nikki D ^a   Bibi, Yuval ^a   Dreiher, Jacob ^b,c   Cohen, Arnon D ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLALIT HEALTH SERVICES   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Dermatology; Zinc; Zinc deficiency

Indexed keywords

BENZOYL PEROXIDE; BETAMETHASONE; CLINDAMYCIN; CLOBETASOL; CLOBETASONE BUTYRATE; EOSIN; ERYTHROMYCIN; FUSIDIC ACID; GLUCONATE ZINC; HERBACEOUS AGENT; KETOCONAZOLE; LACTIC ACID PLUS SALICYLIC ACID; MEGLUMINE ANTIMONATE; MINOXIDIL; PLACEBO; PYRITHIONE ZINC; TACROLIMUS; TETRACYCLINE; TITANIUM DIOXIDE; ZINC ACETATE; ZINC DERIVATIVE; ZINC OXIDE; ZINC SULFATE;

ACNE VULGARIS; ACRODERMATITIS ENTEROPATHICA; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; APHTHOUS ULCER; BEHCET DISEASE; CHLOASMA; CLINICAL TRIAL; DANDRUFF; DIAPER DERMATITIS; DIARRHEA; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ECZEMA; ERYTHEMA; FOLLICULITIS; FOLLICULITIS DECALVANS; HAIR DISEASE; HUMAN; LEPROSY; MALE TYPE ALOPECIA; NAUSEA; NECROLYTIC ACRAL ERYTHEMA; NEUTROPHIL CHEMOTAXIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SKIN LEISHMANIASIS; SKIN ULCER; SUPPURATIVE HIDRADENITIS; TEA; TELOGEN EFFLUVIUM; TREATMENT RESPONSE; VERRUCA VULGARIS; VOMITING; ZINC DEFICIENCY;

FEMALE; HUMANS; MALE; SKIN DISEASES; THERAPIES, INVESTIGATIONAL; ZINC;

EID: 77953257041     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2010.03.006     Document Type: Review

References (116)

1. Raulin J. Etudes cliniques sur la vegetation. Ann Sci Nat Bot Biol Veg 1869, 11:93.
2. Coleman J. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 1992, 61:897-946.
3. Prasad A. Zinc and enzymes 1993, Plenum Press, New York.
4. Prasad A. Zinc and gene expression 1993, Plenum Press, New York.
5. Hernick M., Fierke C. Zinc hydrolases: the mechanisms of zinc-dependent deacetylases. Arch Biochem Biophys 2005, 433:71-84.
6. Vallee B., Falchuk K. The biochemical basis of zinc physiology. Physiol Rev 1993, 73:79-118.
7. Prasad A. Zinc deficiency. BMJ 2003, 326:409-410.
8. King J., Shames D., Woodhouse L. Zinc homeostasis in humans. J Nutr 2000, 130(5S Suppl):1360S-1366S.
9. Murphy E., Willis B., Watt B. Provisional tables on the zinc content of foods. J Am Diet Assoc 1975, 66:345-355.
10. Hunt J. Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am J Clin Nutr 2003, 78(3 Suppl):633S-639S.
11. Krebs N. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr. 2000, 130(5S Suppl):1374S-1377S.
12. Bibi Nitzan Y., Cohen A. Zinc in skin pathology and care. J Dermatolog Treat 2006, 17(4):205-210.
13. Prasad A., Halsted J., Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am J Med 1961, 31:532-546.
14. Prasad A. Zinc in growth and development and spectrum of human zinc deficiency. J Am Coll Nutr 1988, 7:377-384.
15. Gibson R. Zinc nutrition in developing countries. Nutr Res Rev 1994, 7:151-173.
16. Prasad A., Miale A., Farid Z., et al. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med 1963, 61:537-549.
17. Sandstead H., Prasad A., Schulert A., et al. Human zinc deficiency, endocrine manifestations and response to treatment. Am J Clin Nutr 1967, 20:422-442.
18. Danbolt N., Closs K. Acrodermatitis enteropathica. Acta Derm Venereol 1942, 23:127-169.
19. Barnes P., Moynahan E. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerance treated with synthetic diet. Proc R Soc Med 1973, 66:327-329.
20. Michaelsson G. Zinc therapy in acrodermatitis enteropathica. Acta Derm Venereol 1974, 54:377-381.
21. Kury S., Dreno B., Bezieau S., et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002, 31:239-240.
22. Perafan-Riveros C., Franca L., Alves A., et al. Acrodermatitis enteropathica: case report and review of the literature. Pediatr Dermatol 2002, 19:426-431.
23. Kay R., Tasman-Jones C., Pybus J., et al. A syndrome of acute zinc deficiency during total parenteral alimentation in man. Ann Surg 1976, 183:331-340.
24. Fitzherbert J. Zinc deficiency in acne vulgaris. Med J Aust 1977, 2:685-686.
25. Amer M., Bahgat M., Tosson Z., et al. Serum zinc in acne vulgaris. Int J Dermatol 1982, 21:481-484.
26. Michaelsson G., Vahlquist A., Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol 1977, 96:283-286.
27. Michaelsson G., Juhlin L., Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977, 113:31-36.
28. Hillstrom L., Pettersson L., Hellbe L., et al. Comparison of oral treatment with zinc sulfate and placebo in acne vulgaris. Br J Dermatol 1977, 97:681-684.
29. Göransson K., Liden S., Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol 1978, 58:443-448.
30. Verma K., Saini A., Dhamija S. Oral zinc sulfate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol 1980, 60:337-340.
31. Liden S., Goransson K., Odsell L. Clinical evaluation in acne. Acta Derm Venereol Suppl (Stockh) 1980, 89(Suppl):47-52.
32. Orris L., Shalita A., Sibulkin D., et al. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol 1978, 114:1018-1020.
33. Weimar V., Puhl S., Smith W., et al. Zinc sulfate in acne vulgaris. Arch Dermatol 1978, 114:1776-1778.
34. Cunliffe W. Unacceptable side-effects of oral zinc sulfate in the treatment of acne vulgaris. Br J Dermatol 1979, 101:363.
35. Dreno B., Amblard P., Agache P., et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol Suppl (Stockh) 1989, 69:541-543.
36. Dreno B., Moyse D., Alirezai M., et al. Multicenter randomized comparative double blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001, 203:135-140.
37. Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol 2000, 10:269-273.
38. Michaelsson G., Juhlin L., Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977, 97:561-566.
39. Sharquie K.E., Noaimi A.A., Al-Salih M.M. Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution. Saudi Med J 2008, 29(12):1757-1761.
40. Feucht C., Allen B., Chalker D., et al. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol 1980, 3:483-491.
41. Habbema L., Koopmans B., Menke H., et al. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study. Br J Dermatol 1989, 121:497-502.
42. Schachner L., Eaglstein W., Kittles C., et al. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol. 1990, 22(2 Pt 1):253-260.
43. Schachner L., Pestana A., Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. J Am Acad Dermatol 1990, 22:489-495.
44. Langner A., Sheehan-Dare R., Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol 2007, 21:311-319.
45. Cochran R., Tucker S., Flannigan S. Topical zinc therapy for acne vulgaris. Int J Dermatol 1985, 24:188-190.
46. Cunliffe W.J., Fernandez C., Bojar R., et al. Zindaclin Clinical Study Group. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. J Dermatolog Treat 2005, 16:213-218.
47. Dreno B., Foulc P., Reynaud A., et al. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005, 15:152-155.
48. Strauss J., Stranieri A. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984, 11:86-89.
49. Toyoda M., Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998, 196:130-134.
50. Bojar R., Eady E., Jones C., et al. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994, 130:329-336.
51. Fluhr J., Bosch B., Gloor M., et al. In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. Zentralbl Bakteriol 1999, 289:445-456.
52. Rebello T., Atherton D., Holden C. The effect of oral zinc administration on sebum free fatty acids in acne vulgaris. Acta Derm Venereol. 1986, 66:305-310.
53. Dreno B., Trossaert M., Boiteau H., et al. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol Suppl (Stockh) 1992, 72:250-252.
54. Pierard G., Pierard-Franchimont C. Effect of a topical erythromycin-zinc formulation on sebum delivery. Evaluation by combined photometric-multi-step samplings with Sebutape. Clin Exp Dermatol 1993, 18:410-413.
55. Pierard-Franchimont C., Goffin V., Visser J., et al. A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex. Eur J Clin Pharmacol 1995, 49:57-60.
56. Van Hoogdalem E., Terpstra I., Baven A. Evaluation of the effect of zinc acetate on the stratum corneum penetration kinetics of erythromycin in healthy male volunteers. Skin Pharmacol 1996, 9:104-110.
57. Degitz K., Ochsendorf F. Pharmacotherapy of acne [review]. Expert Opin Pharmacother 2008, 9:955-971.
58. Sharquie K.E., Najim R.A., Al-Salman H.N. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. Int J Dermatol 2006, 45:857-861.
59. Ead R. Oral zinc sulfate in alopecia areata - a double blind trial. Br J Dermatol 1981, 104:483-484.
60. Brocard A., Knol A.C., Khammari A., et al. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology 2007, 214:325-327.
61. Abeck D., Korting H.C., Braun-Falco O. Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol 1992, 72:143-145.
62. Najim R.A., Sharquie K.E., Abu-Raghif A.R. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters. J Dermatol 2007, 34:308-314.
63. Sharquie K.E., Najim R.A., Al-Dori W.S., et al. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study. J Dermatol 2006, 33:541-546.
64. Berger R., Fu J., Smiles K., et al. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol 2003, 149:354-362.
65. Rushton D. Nutritional factors and hair loss. Clin Exp Dermatol 2002, 27:396-404.
66. Warner R., Schwartz J., Boissy Y., et al. Dandruff has an zinc pyrithione shampoo. J Am Acad Dermatol 2001, 45:897-903.
67. Imokawa G., Okamoto K. The inhibitory effect of zinc pyrithione on the epidermal proliferation of animal skins. Acta Derm Venereol 1982, 62:471-475.
68. Gibson W., Hardy W., Groom M. The effect and mode of action of zinc pyrithione on cell growth. II. In vivo studies. Food Chem Toxicol 1985, 23:103-110.
69. Gupte T., Gaikwad U., Naik S. Experimental studies (in vitro) on polyene macrolide antibiotics with special reference to hamycin against Malassezia ovale. Comp Immunol Microbiol Infect Dis 1999, 22:93-102.
70. Schmidt A., Ruhl-Horster B. In vitro susceptibility of Malassezia furfur. Arzneimittelforschung 1996, 46:442-444.
71. Marks R., Pearse A., Walker A. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985, 112:415-422.
72. Rapaport M. A randomized, controlled clinical trial of four anti-dandruff shampoos. J Int Med Res 1981, 9:152-156.
73. Pierard-Franchimont C., Goffin V., Decroix J., et al. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002, 15:434-441.
74. Shin H., Kwon O.S., Won C.H., et al. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study. J Dermatol 2009, 36(3):131-137.
75. Van Coevorden A.M., Coenraads P.J., Svensson A. Overview of studies of treatments for hand eczema the EDEN hand eczema survey. Br J Dermatol 2004, 151:446.
76. Faghihi G., Iraji F., Shahingohar A., et al. The efficacy of 0.05% Clobetasol + 2.5% zinc sulfate' cream vs. 0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. J Eur Acad Dermatol Venereol 2008, 22:531-536.
77. Lansdown A. Zinc in the healing wound. Lancet 1996, 347:706-707.
78. Baldwin S., Odio M.R., Haines S.L., et al. Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper. J Eur Acad Dermatol Venereol 2001, 15(Suppl 1):5-11.
79. Arad A., Ben-Amitai D., Zeharia A., et al. Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis. Dermatology 1999, 199:319-322.
80. Wananukul S., Limpongsanuruk W., Singalavanija S., et al. Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai 2006, 89:1654-1658.
81. Al-Gurairi F., Al-Waiz M., Sharquie K. Oral zinc sulfate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002, 146:423-431.
82. Gibbs S. Zinc sulfate for viral warts. Br J Dermatol 2003, 148:1082-1083.
83. Sadighha A. Oral zinc sulfate in recalcitrant multiple viral warts: a pilot study. J Eur Acad Dermatol Venereol 2009, 23:715-716.
84. Yaghoobi R., Sadighha A., Baktash D. Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol 2009, 60:706-708.
85. Sharquie K.E., Khorsheed A.A., Al-Nuaimy A.A. Topical zinc sulfate solution for treatment of viral warts. Saudi Med J 2007, 28:1418-1421.
86. Khattar J.A., Musharrafieh U.M., Tamim H., et al. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol 2007, 46:427-430.
87. Sharquie K., Najim R., Farjou I., et al. Oral zinc sulfate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001, 26:21-26.
88. Firooz A., Khatami A., Khamesipour A., et al. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, doubleblind, controlled clinical trial. J Drugs Dermatol 2005, 4:73-79.
89. Iraji F., Vali A., Asilian A., et al. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology 2004, 209:46-49.
90. Sharquie K., Najim R., Farjou I. A comparative controlled trial of intralesionally-administered zinc sulfate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol 1997, 22:169-173.
91. Sharquie K.E., Najim R.A. Disseminated cutaneous leishmaniasis. Saudi Med J 2004, 25:951-954.
92. Minodier P., Parola P. Cutaneous leishmaniasis treatment [review]. Travel Med Infect Dis 2007, 5:150-158.
93. Nofal A.A., Nofal E., Attwa E., et al. Necrolytic acral erythema: a variant of necrolytic migratory erythema or a distinct entity?. Int J Dermatol 2005, 44(11):916-921.
94. de Carvalho Fantini B., Matsumoto F.Y., Arnone M., et al. Necrolytic acral erythema successfully treated with oral zinc. Int J Dermatol 2008, 47(8):872-873.
95. Khanna V.J., Shieh S., Benjamin J., et al. Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc. Arch Dermatol 2000, 136:755-757.
96. Abdallah M.A., Hull C., Horn T.D. Necrolytic acral erythema: a patient from the United States successfully treated with oral zinc. Arch Dermatol 2005, 141:85-87.
97. Geria A.N., Holcomb K.Z., Scheinfeld N.S. Necrolytic acral erythema: a review of the literature [review]. Cutis 2009, 83:309-314.
98. Rowlands C., Danby F. Histopathology of psoriasis treated with zinc pyrithione. Am J Dermatopathol 2000, 22:272-276.
99. Housman T., Keil K., Mellen B., et al. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol 2003, 49:79-82.
100. Burrows N., Turnbull A., Punchard N., et al. A trial of oral zinc supplementation in psoriasis. Cutis 1994, 54:117-118.
101. Rojas A., Phillips T. Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc. Dermatol Surg 1999, 25:601-604.
102. Posthauer M.E. Do patients with pressure ulcers benefit from oral zinc supplementation? [review]. Adv Wound Care 2005, 18:471-472.
103. Ackerman Z., Loewenthal E., Seidenbaum M., et al. Skin zinc concentrations in patients with varicose ulcers. Int J Dermatol 1990, 29:360-362.
104. Brandrup F., Menne T., Agren M., et al. A randomized trial of two occlusive dressings in the treatment of leg ulcers. Acta Derm Venereol Suppl (Stockh) 1990, 70:231-235.
105. Stromberg H., Agren M. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 1984, 111:461-468.
106. Agren M., Stromberg H. Topical treatment of pressure ulcers. A randomized comparative trial of Varidase and zinc oxide. Scand J Plast Reconstr Surg 1985, 19:97-100.
107. Apelqvist J., Larsson J., Stenstrom A. Topical treatment of necrotic foot ulcers in diabetic patients: a comparative trial of DuoDerm and MeZinc. Br J Dermatol 1990, 123:787-792.
108. Agren M. Studies on zinc in wound healing. Acta Derm Venereol Suppl (Stockh) 1990, 154:1-36.
109. Wilkinson E., Hawke C. Oral zinc for arterial and venous leg ulcers. Cochrane Database Syst Rev 2000, (2). CD001273.
110. Cereda E., Gini A., Pedrolli C., et al. Disease-specific, versus standard, nutritional support for the treatment of pressure ulcers in institutionalized older adults: a randomized controlled trial. J Am Geriatr Soc 2009, 57:1395-1402.
111. Desneves K.J., Todorovic B.E., Cassar A., et al. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomized controlled trial. Clin Nutr 2005, 24:979-987.
112. Michaelsson G., Ljunghall K., Danielson B. Zinc in epidermis and dermis in healthy subjects. Acta Derm Venereol 1980, 60:295-299.
113. Michaelsson G., Ljunghall K. Patients with dermatitis herpetiformis, acne, psoriasis and Darier's disease have low epidermal zinc concentrations. Acta Derm Venereol 1990, 70:304-308.
114. Bolanca I., Bolanca Z., Kuna K., et al. Chloasma-the mask of pregnancy [review]. Coll Antropol 2008, 32(Suppl 2):139-141.
115. Sharquie K.E., Al-Mashhadani S.A., Salman H.A. Topical 10% zinc sulfate solution for treatment of melasma. Dermatol Surg 2008, 34:1346-1349.
116. Reinar L.M., Forsetlund L., Bjørndal A., et al. Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database Syst Rev 2008, 3. CD004833.